Uterine Serous Adenocarcinoma in an Elderly Postmenopausal Woman: Clinically Misdiagnosed as Uterine Cervix Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Uterine serous adenocarcinoma (USC) is rare and invasive cancer. This cancer is more often reported in the ovary, the fallopian tube, and the endometrium than uterine cervix. No matter where the tumor is located, the tumor exhibits similar histological characteristics. So when uterine cancer is proven to be serous adenocarcinoma, it is necessary to see if the tumor originated from ovary or endometrium and invaded the cervix. We report a case of a 73-year-old postmenopausal woman with USC arising near the internal os of endocervical canal, clinically misdiagnosed as uterine cervix cancer. (J Menopausal Med 2015;21:171-174)
Abstract
Uterine serous adenocarcinoma (USC) is rare and invasive cancer. This cancer is more often reported in the ovary, the fallopian tube, and the endometrium than uterine cervix. No matter where the tumor is located, the tumor exhibits similar histological characteristics. So when uterine cancer is proven to be serous adenocarcinoma, it is necessary to see if the tumor originated from ovary or endometrium and invaded the cervix. We report a case of a 73-year-old postmenopausal woman with USC arising near the internal os of endocervical canal, clinically misdiagnosed as uterine cervix cancer. (J Menopausal Med 2015;21:171-174)
참고문헌 (7)
- Hendrickson M., "Uterine papillary serous carcinoma : a highly malignant form of endometrial adenocarcinoma", Am J Surg Pathol, 6, pp.93~108 (1982)
- 허은진, "A Case of Perimenopausal Endometrial Cancer in a Woman with MSH2 Germline Mutation", 대한폐경학회지, 19(3), pp.143~146 (2013), 대한폐경학회
- Jung-Woo Park, "Abdominal Wall Metastasis of Uterine Papillary Serous Carcinoma in a Post-Menopausal Woman: A Case Report", 대한폐경학회지, 20(1), pp.35~38 (2014), 대한폐경학회
- 최승도, "Ezrin is an Essential Marker for Metastasis of Gynecologic Cancer", 대한폐경학회지, 18(2), pp.81~93 (2012), 대한폐경학회[DOI]
- 박정우, "Discrimination between Benign and Malignant Pelvic Masses Using the Risk of Malignancy Index 1", 대한폐경학회지, 19(1), pp.18~25 (2013), 대한폐경학회
- 박정민, "Hereditary Risk Evaluation for Borderline Ovarian Tumors Based on Immunohistochemistry", 대한폐경학회지, 20(1), pp.14~20 (2014), 대한폐경학회
- 이희숙, "조기폐경 환자에서의 호르몬 치료에 대한 순응도 분석", 대한폐경학회지, 19(2), pp.87~92 (2013), 대한폐경학회